CN1137920A - Patent drug for curing sciatica - Google Patents
Patent drug for curing sciatica Download PDFInfo
- Publication number
- CN1137920A CN1137920A CN 96108601 CN96108601A CN1137920A CN 1137920 A CN1137920 A CN 1137920A CN 96108601 CN96108601 CN 96108601 CN 96108601 A CN96108601 A CN 96108601A CN 1137920 A CN1137920 A CN 1137920A
- Authority
- CN
- China
- Prior art keywords
- chinese patent
- medicine
- patent medicine
- chinese
- weight proportion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 208000008765 Sciatica Diseases 0.000 title claims abstract description 11
- 229940079593 drug Drugs 0.000 title abstract description 3
- 239000002994 raw material Substances 0.000 claims description 12
- 241000972155 Moschus Species 0.000 claims description 9
- 241001530038 Pantherophis obsoletus Species 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 7
- 241000283956 Manis Species 0.000 claims description 7
- 241000237636 Pheretima Species 0.000 claims description 7
- 241000131808 Scolopendra Species 0.000 claims description 7
- 241000522620 Scorpio Species 0.000 claims description 6
- 239000009490 scorpio Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 241001254604 Angelica pubescens Species 0.000 abstract 1
- 244000080208 Canella winterana Species 0.000 abstract 1
- 235000008499 Canella winterana Nutrition 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 229940017545 cinnamon bark Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 16
- 230000036407 pain Effects 0.000 description 15
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 230000017531 blood circulation Effects 0.000 description 9
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 5
- 230000002175 menstrual effect Effects 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 210000003497 sciatic nerve Anatomy 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PBQVHWFDMNCCIH-KNJAVFAGSA-N (4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;n,n-dimethyl-1-phenothiazin-10-ylpropan-2-amine;n-(4-hydroxyphenyl)acetamide;phosphoric acid;hydrochloride Chemical compound Cl.OP(O)(O)=O.CC(=O)NC1=CC=C(O)C=C1.C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1.C([C@H]1C(N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC PBQVHWFDMNCCIH-KNJAVFAGSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese patent drug for curing ischias with 95% effective rate, 85% cure rate and no toxic by-effect is prepared from 13 Chinese-medicinal materials such as pubescent angelica root, cinnamon bark, earthworm, pangolin scales, eucommia bark, etc.
Description
The invention belongs to the medicine of treatment sciatica, specifically a kind of is the Chinese patent medicine of feedstock production with the Chinese herbal medicine.
Sciatica is meant forms the various causes of disease influences of originally experiencing of sciatic nerve root, plexus nervorum or nerve trunk, causes a kind of disease of pain in sciatic nerve path and the areal area thereof.Belong to Chinese medical ' arthralgia syndrome ' category, show as aching and tired, the pain of back and lower limb clinically, localized pain gets warm can the alleviation, and tired or chance is cold then more very, and the primary disease course of disease is long, and the touching difficulty of patient's condition more.At present therapies such as acupuncture, massage, cupping jar that adopt more, its weak point is that treatment time is long, it is slow to take effect, and can not effect a radical cure; Though with this disease of treatment by Chinese herbs certain curative effect is arranged, awaits further to improve.
Purpose of the present invention aims to provide the Chinese patent medicine of the treatment sciatica of a kind of good effect, instant effect.
Solution of the present invention is to form in conjunction with theory of Chinese medical science and clinical experience research for many years.Sciatica belongs to Chinese medical ' arthralgia syndrome ' category, " wind, cold, wet three gas are assorted extremely; close and be numbness ", the traditional Chinese medical science thinks that " arthromyodynia " is because human body vital essence deficiency, anti-evil unable, wind, cold, wet heresy are taken advantage of a weak point, and condense mutually, the retardance venation, cause QI and blood numbness resistance, must not be unobstructed, stagnation of QI and blood may bring about pain and forming, its treatment is taked dispelling wind, cold expelling, heat clearing away, dehumidifying respectively by the different causes of disease, but disease is then gone into network for a long time for a long time bitterly, and prolonged illness must be empty, will cause the resistance of the blood network stasis of blood, deficiency of both the liver and kidney, always should get rid of evils to set upright, promoting blood circulation to restore menstrual flow for its sick this.Therefore, the inventor proposes the principles of formulating prescriptions of " relieving rheumatism and cold, invigorating blood circulation and stopping pains, warming the meridian and promoting blood circulation, removing blood stasis stimulates the menstrual flow ".
Chinese patent medicine of the present invention adopts following Chinese medicine raw materials by weight proportion (b is Unit Weight part):
Radix Angelicae Pubescentis 1-5b Cortex Cinnamomi 2-6b Pheretima 1-5b Squama Manis 2-10b
Cortex Eucommiae 3-7b Flos Carthami 1-5b Scorpio 1-3b black-snake 2-6b
Scolopendra 1-3b Herba speranskiae tuberculatae 3-7b Herba Aristolochiae Mollissimae 2-6b Resina Liquidambaris 1-5b
Moschus 0.5-2b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
Radix Angelicae Pubescentis in the side rheumatism of loosing, pain relieving; Cortex Cinnamomi warming middle-JIAO YANG invigorating, dispersing cold for relieving pain; Pheretima heat clearing away arresting convulsion, collateral dredging; The Squama Manis detumescence and apocenosis stimulates the menstrual flow; Cortex Eucommiae invigorating the liver and kidney, strengthening bone and muscle; The Flos Carthami blood circulation promoting competent silt, inducing menstruation to relieve menalgia; The Scorpio spasmolytic that relieves dizziness, high fever, infantile convulsions, epilepsy, etc. is separated sore; The black-snake dispelling wind and removing obstruction in the collateral; The Scolopendra spasmolytic that relieves dizziness, high fever, infantile convulsions, epilepsy, etc. is separated sore, Serpentis poison; The Herba speranskiae tuberculatae wind damp eliminating of loosing, the detoxifcation pain relieving; The Herba Aristolochiae Mollissimae collateral dredging is invigorated blood circulation, wind-expelling pain-stopping; The Resina Liquidambaris promoting blood circulation and hemostasis, the collateral dredging detoxifcation; Moschus is invigorated blood circulation, collateral dredging, pain relieving.
The property of medicine of above medicine meets the principle of medication of the traditional Chinese medical science to sciatica, and consistent with its principles of formulating prescriptions " relieving rheumatism and cold, invigorating blood circulation and stopping pains, warming the meridian and promoting blood circulation, removing blood stasis stimulates the menstrual flow ".
The inventor once treated over thousands of routine patient with this medicine, all obtained promising result, and found no toxic and side effects.According to 100 routine patients of following criterion of therapeutical effect clinical observation, total effective rate reaches 95%, and cure rate reaches 85%.
Criterion of therapeutical effect:
Cure---treat a course of treatment (10 days) afterwards disease sites pain stop energy
Normal activity, and do not recur for a long time.
Effectively---treat disease sites pain relief after a course of treatment, limb activity is controlled
Make moderate progress before the treatment.
Invalid---no change before and after the treatment.
Model case:
The Guan Zhenwang village, county town village newly falls in 53 years old Shanxi Province of king rabbit man
Pain can not be walked unbearably when suffering from this disease in 1988, can only lie on a bed, and takes this medicine after 7 days, and disease sites pain stops, can normal activity, not recurrence so far.
The military man of Ruan Jing 52 years old Shanxi Province Hejin County girder township Liu Cun
This person is driver, suffered from 1988 this when sick pain can not go out car unbearably, take this medicine after 7 days, disease sites pain stops, and can normally go out car, so far not recurrence.
The present invention has caught the basic cause of disease of sciatica, treating both the principal and secondary aspects of a disease, and its effective percentage reaches 95%, and cure rate reaches 85%, and treatment time is short, finds no toxic and side effects.So the present invention has curative effect height, instant effect, advantage that toxic and side effects is little.
Embodiment 1, and present embodiment adopts following Chinese medicine raw materials by weight proportion (b is Unit Weight part):
Radix Angelicae Pubescentis 3b Cortex Cinnamomi 4b Pheretima 3b Squama Manis 6b
Cortex Eucommiae 5b Flos Carthami 3b Scorpio 2b black-snake 4b
Scolopendra 2b Herba speranskiae tuberculatae 5b Herba Aristolochiae Mollissimae 4b Resina Liquidambaris 3b
Moschus 1b
Above-mentioned Chinese medicine raw materials by weight proportion is made capsule or close ball type oral Chinese patent medicine.
Method for making:
Radix Angelicae Pubescentis, Cortex Cinnamomi were soaked 1 hour with spilling in vain, dried; Black-snake is decaptitated and is truncated; The Moschus list grinds; All the other whole pulverizations add ground Moschus then, mix homogeneously powder.
Dosage form: 1, capsule: during above-mentioned powder incapsulated, every heavy 0.25 gram;
2, close ball: by known close ball method for making, above-mentioned powder adds an amount of Mel system
Become close ball, every ball weighs 3 grams.
Usage: capsule--every day 3-4 time, each 4, boiled water takes;
Close ball---every day 3-4 time, each 1 ball, boiled water takes.
More than serveing on 10 days is a course of treatment.
Embodiment 2, and present embodiment adopts following Chinese medicine raw materials by weight proportion (b is Unit Weight part);
Radix Angelicae Pubescentis 1b Cortex Cinnamomi 2b Pheretima 1b Squama Manis 2b
Cortex Eucommiae 3b Flos Carthami 1b Scorpio 1b black-snake 2b
Scolopendra 1b Herba speranskiae tuberculatae 3b Herba Aristolochiae Mollissimae 2b Resina Liquidambaris 1b
Moschus 0.5b
Above-mentioned Chinese medicine raw materials by weight proportion is made capsule or close ball type oral Chinese patent medicine.
Embodiment 3, and present embodiment adopts following Chinese medicine raw materials by weight proportion (b is Unit Weight part):
Radix Angelicae Pubescentis 5b Cortex Cinnamomi 6b Pheretima 5b Squama Manis 10b
Cortex Eucommiae 7b Flos Carthami 5b JINCHONG 3b black-snake 6b
Scolopendra 3b Herba speranskiae tuberculatae 7b Herba Aristolochiae Mollissimae 6b Resina Liquidambaris 5b
Moschus 2b
Above-mentioned Chinese medicine raw materials by weight proportion is made capsule or close ball type oral Chinese patent medicine.
Claims (2)
1, a kind of Chinese patent medicine for the treatment of sciatica is characterized in that: this Chinese patent medicine adopts following Chinese medicine raw materials by weight proportion (b is Unit Weight part):
Radix Angelicae Pubescentis 1-5b Cortex Cinnamomi 2-6b Pheretima 1-5b Squama Manis 2-10b
Cortex Eucommiae 3-7b Flos Carthami 1-5b Scorpio 1-3b black-snake 2-6b
Scolopendra 1-3b Herba speranskiae tuberculatae 3-7b Herba Aristolochiae Mollissimae 2-6b Resina Liquidambaris 1-5b
Moschus 0.5-2b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
2, the Chinese patent medicine of treatment sciatica according to claim 1 is characterized in that: the raw material of Chinese medicine of described Chinese patent medicine adopts following weight proportion (b is Unit Weight part):
Radix Angelicae Pubescentis 3b Cortex Cinnamomi 4b Pheretima 3b Squama Manis 6b
Cortex Eucommiae 5b Flos Carthami 3b Scorpio 2b black-snake 4b
Scolopendra 2b Herba speranskiae tuberculatae 5b Herba Aristolochiae Mollissimae 4b Resina Liquidambaris 3b
Moschus 1b
Above-mentioned Chinese medicine raw materials by weight proportion is made capsule or close ball type oral Chinese patent medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96108601 CN1137920A (en) | 1996-06-11 | 1996-06-11 | Patent drug for curing sciatica |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96108601 CN1137920A (en) | 1996-06-11 | 1996-06-11 | Patent drug for curing sciatica |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1137920A true CN1137920A (en) | 1996-12-18 |
Family
ID=5120015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 96108601 Pending CN1137920A (en) | 1996-06-11 | 1996-06-11 | Patent drug for curing sciatica |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1137920A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001091771A3 (en) * | 2000-06-01 | 2003-01-30 | Theralife Inc | Compositions for treating back and leg discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| CN101664527B (en) * | 2009-10-21 | 2011-06-01 | 李建德 | Chinese traditional medicine for curing sciatica |
-
1996
- 1996-06-11 CN CN 96108601 patent/CN1137920A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001091771A3 (en) * | 2000-06-01 | 2003-01-30 | Theralife Inc | Compositions for treating back and leg discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| CN101664527B (en) * | 2009-10-21 | 2011-06-01 | 李建德 | Chinese traditional medicine for curing sciatica |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1294981C (en) | Arthralgia treating plaster | |
| CN1211103C (en) | Oral and external medicine for dispelling wind-damp and stopping arthralgia and preparation method thereof | |
| CN1923234A (en) | Traditional Chinese medicinal formulation for treating osteoarthropathy | |
| CN1124156C (en) | Chinese-medicinal pills for treating rheumatism and preparing process thereof | |
| CN1471938A (en) | Medicine for treating superficial and deep burn and scald | |
| CN1135909A (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
| CN1074676C (en) | Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof | |
| CN1478525A (en) | Medicated wine for treating traumatic injury | |
| CN1137920A (en) | Patent drug for curing sciatica | |
| CN1181878C (en) | Detumescence plaster | |
| CN102406870A (en) | Medicine for treating rheumatic arthralgia | |
| CN1101202C (en) | Compound Chinese medicine preparation for treating hyperosteogeny | |
| CN1092968C (en) | Pharmaceuticals for treating outer skin blood vessel diease in cold seasons | |
| CN1164324C (en) | Chiese medicine preparation for treating parenchyma pain | |
| CN1284576C (en) | External-use Chinese medicine for treating osteoproliferation and its preparing method | |
| CN1602905A (en) | Externally applied medicine for treating hyperosteogeny and intervertebral disc protrusion and its preparation method | |
| CN1117583C (en) | Medicine for curing lumbago | |
| CN1404850A (en) | Anti-inflammatory pain-releaving and swelling-diminishing external-use medicine | |
| CN1876081A (en) | A medicinal tincture and method for preparing same | |
| CN1236798C (en) | External medicine for treating bone tuberculosis | |
| CN1115160C (en) | Orally-applied medicine for treating hyperosteogeny | |
| CN1857636A (en) | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny | |
| CN1273167C (en) | Medicine for external application for curing rheumatism and its preparation method | |
| CN1720938A (en) | Medicine for treating rheumatic arthritis and ankylosing spondylitis and its preparing process | |
| CN1275631C (en) | Externally applied herbal liquor having special therapeutic effect for rheumatic arthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |